Today’s CSR movers
FOX 4.2 ▲ 1.5
FOXA 3.7 ▲ 1.2
AEE 4.0 ▲ 1.2
KMI 3.3 ▼ 0.4
ES 2.0 ▼ 1.0
EIX 2.0 ▼ 1.1
SO 2.0 ▼ 1.1
ETR 2.9 ▼ 1.2
CSX 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
Health Care · NYSE NYSE · LLY

Eli Lilly & Co

$1,255.40 +$1,104.75 +88.00% CLOSE 08.21.26
Convergence score
4.1 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$1,301.54 +3.7%
Range $850.00 — $1,600.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 08.21.26
UV Convergence Score
REPORT 08.21.26
4.1
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.6
Multi-signal aggregate How CSR works →
Day Range
52W Range
Volume
Avg Vol
Mkt Cap
$1.12T
P/E
42.66
EPS (TTM)
$29.43
Div Yield
0.55%
Beta
0.58
Today's convergence

Convergence score sits at 4.1 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
STRONG BULLISH
Last close
$1,255.40
Sector
Health Care
Valuation
Three horizons
UPDATED 08.21.26
Short term
0–3 MO
No target Strong Buy
Medium term
3–12 MO
$1,292+2.9% Buy
Long term
12–36 MO
$463.84-63.1% Overvalued
Open valuation
Analysts
Coverage & consensus
3 PANELS
Mean target (12mo)
$1,301.54 +3.7%
RANGE $850.00 — $1,600.00
Analyst consensus
Consensus rating Buy
Blended score 4.2 / 5
Analysts tracked 88
Open analysts
Financials
Key metrics
LATEST
P/E
42.66
EPS (TTM)
$29.43
Mkt Cap
$1.12T
Div Yield
0.55%
Beta
0.58
52W Range
Open financials
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in
Valuation breakdown

Three horizons, one consensus.

UPDATED 08.21.26
Short term
0–3 MO
Strong Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$1,292 +2.9%
RANGE $850 – $1,600
$850NOW $1,255.40$1,600

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$463.84 -63.1%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 08.21.26
Analyst consensus
Rating Blended score Panels Analysts
Buy 4.2 3 88
Price targets
Coverage Low Mean Median High Upside
All panels $850.00 $1,301.54 $1,600.00 +3.7%
Rating distribution
Coverage SB B H S SS
All panels 1 24 4 1
Rating trend
Period Rating Avg Analysts
Current Strong Buy 4.62 29
1 Mo Ago Strong Buy 4.62 29
2 Mo Ago Strong Buy 4.63 30
3 Mo Ago Strong Buy 4.63 30
Most recent analyst action
Date
8/11/2026
Firm
Weiss Ratings
Action
Downgrade
Rating
Buy (B) ➝ Buy (B-)
Target
Financials

Full financial snapshot.

UPDATED 08.21.26
Quote snapshot
Prev Close
Open
Day Low
Day High
Bid
Ask
52W Low
52W High
50D Avg
1,179.58
200D Avg
1,052.98
Volume
Avg Vol
10D Avg Vol
52W Change
+77.96%
S&P 52W Change
Valuation ratios
P/E (TTM)
42.14
P/E (Fwd)
30.78
PEG (Fwd)
1.46
P/S
14.05
P/B
33.03
Book Value
38.00
EV/Revenue
14.61
EV/EBITDA
27.91
Mkt Cap
1.12T
Enterprise Val
1.16T
Profitability & returns
Profit Margin
33.53%
Gross Margin
83.40%
Operating Margin
49.72%
EBITDA Margin
52.35%
Return on Assets
20.36%
Return on Equity
102.29%
Growth
Revenue Growth (YoY)
Earnings Growth (YoY)
Earnings Growth (Q)
Balance sheet & cash flow
Total Revenue
79.67B
EBITDA
41.71B
Total Cash
Total Debt
54.91B
Cash / Share
Revenue / Share
Free Cash Flow
18.19B
Operating CF
28.08B
Debt / Equity
1.62
Current Ratio
1.35
Quick Ratio
0.68
Dividend
Fwd Dividend
$6.92
Dividend Yield
0.55%
Payout Ratio
22.46%
5Y Avg Yield
Ex-Div Date
Aug 14, 2026
Share statistics
Shares Out
891.36M
Float
888.95M
Shares Short
9.12M
% Short of Float
1.03%
Short Ratio
3.69
% Held Insiders
0.17%
% Held Institutions
89.30%
Calendar & events
Next Earnings
Aug 5, 2026
Fiscal Year End
Most Recent Qtr
Last Split
Split Date
Company
Industry
Employees